• Price to earnings forward of Cardiff Oncology, Inc. – NASDAQ:CRDF TradingView Tue, 07 Jul 2026 20:37:52 GMT
• enterprise value to ebit forward of cardiff oncology, inc. – tradegate:xe7c TradingView Mon, 06 Jul 2026 13:12:05 GMT
• price to book forward of cardiff oncology, inc. – nasdaq:crdf TradingView Sun, 05 Jul 2026 13:50:12 GMT
• Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential? Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Cardiff Oncology, Inc.(NasdaqCM:CRDF) dropped from Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 20:31:56 GMT
• Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 08:06:47 GMT
• Cardiff Oncology, Inc.(NasdaqCM:CRDF) dropped from Russell Small Cap Comp Value Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 3000 Value Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• 5 Most Promising Cancer Stocks According to Wall Street Analysts Insider Monkey Sun, 28 Jun 2026 07:00:00 GMT
• Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director TANNENBAUM RENEE P Moomoo Sat, 27 Jun 2026 20:12:05 GMT
• cardiff oncology inc (crdf) financial health: profitability & balance sheet analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• cardiff oncology inc (crdf) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Insider Buying: Mani Mohindru Acquires Shares of Cardiff Oncology Inc (CRDF) GuruFocus Mon, 22 Jun 2026 15:18:03 GMT
• Form 4 Cardiff Oncology Inc For: 22 June By Investing.com Investing.com Nigeria Mon, 22 Jun 2026 13:36:51 GMT
• cardiff oncology director gary pace buys $36,600 in stock Investing.com Mon, 22 Jun 2026 13:34:42 GMT
• Cardiff Oncology (CRDF) CEO makes open-market buy of 24,703 shares Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Cardiff Oncology (CRDF) director Gary W. Pace buys 30,000 shares in open market Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• Cardiff Oncology CEO Mani Mohindru buys $29,890 in company stock By Investing.com Investing.com Nigeria Mon, 22 Jun 2026 07:00:00 GMT
• cardiff oncology inc (crdf) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• cardiff oncology inc (crdf) risk assessment: volatility, financial risk & investment risk TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• cardiff oncology (crdf) stifel 2025 healthcare conference summary Quartr Fri, 19 Jun 2026 17:29:49 GMT
• cardiff oncology inc (crdf) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• cardiff oncology inc (crdf) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• cardiff oncology inc (crdf) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• cardiff oncology inc (crdf) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• cardiff oncology inc (crdf) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 13:17:20 GMT
• cardiff oncology inc (crdf) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 12:54:40 GMT
• cardiff oncology inc (crdf) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 05:58:35 GMT
• cardiff oncology inc (crdf) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 05:52:53 GMT
• cardiff oncology inc (crdf) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 05:52:47 GMT
• cardiff oncology inc (crdf) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 05:49:43 GMT
• cardiff oncology (crdf) director receives 40,565 stock options at $1.59 strike Stock Titan Tue, 16 Jun 2026 01:39:54 GMT
• director james o. armitage awarded 40,565 cardiff oncology (crdf) stock options Stock Titan Tue, 16 Jun 2026 01:39:54 GMT
• director gary w. pace granted 40,565 cardiff oncology (crdf) stock options at $1.59 Stock Titan Tue, 16 Jun 2026 01:39:54 GMT
• cardiff oncology (crdf) director receives grant of 40,565 stock options at $1.59 Stock Titan Tue, 16 Jun 2026 01:39:50 GMT
• Director Gary W. Pace granted 40,565 Cardiff Oncology (CRDF) stock options at $1.59 Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Cardiff Oncology (CRDF) director receives 40,565 stock options at $1.59 strike Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Director James O. Armitage awarded 40,565 Cardiff Oncology (CRDF) stock options Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Cardiff Oncology (CRDF) director receives grant of 40,565 stock options at $1.59 Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• cardiff oncology (crdf) holds steady near support amid low-volume trading - triple ema dars.gov.et Fri, 12 Jun 2026 07:00:00 GMT
• cardiff oncology (crdf) shareholders back board, auditor and equity plan Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastatic Colorec... Seeking Alpha Sun, 07 Jun 2026 07:00:00 GMT
• crdf q1 2026 earnings: wider-than-expected loss as clinical pipeline progresses - quarterly earnings report dars.gov.et Sun, 07 Jun 2026 07:00:00 GMT
• lucid capital maintains cardiff oncology(crdf.us) with buy rating, cuts target price to $4 富途牛牛 Fri, 05 Jun 2026 07:00:00 GMT
• crdf technical analysis | trend, signals & chart patterns | cardiff oncology inc (nasdaq:crdf) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• cardiff oncology inc at td cowen healthcare conference transcript GuruFocus Thu, 04 Jun 2026 20:03:23 GMT
• william blair maintains cardiff oncology(crdf.us) with buy rating 富途牛牛 Thu, 04 Jun 2026 12:54:47 GMT
• Cardiff Onvansertib Shows 72% Response Rate in RAS-Mutated Colorectal Cancer The Clinical Trial Vanguard Thu, 04 Jun 2026 07:00:00 GMT
• asco 2026: interim data released for upcoming braf and ras mcrc therapies Clinical Trials Arena Thu, 04 Jun 2026 07:00:00 GMT
• craig-hallum maintains cardiff oncology(crdf.us) with hold rating, maintains target price $2 Moomoo Thu, 04 Jun 2026 07:00:00 GMT
• cardiff oncology (crdf) faces downgrade amid phase ii study upda GuruFocus Thu, 04 Jun 2026 02:13:54 GMT
• andy hsieh reaffirms buy on cardiff oncology as onvansertib data and streamlined phase iii design strengthen risk‑reward profile TipRanks Wed, 03 Jun 2026 19:31:37 GMT
• cardiff oncology inc call on updated phase 2 crdf-004 transcript GuruFocus Wed, 03 Jun 2026 12:30:00 GMT
• Cardiff Oncology (CRDF) Faces Downgrade Amid Phase II Study Upda GuruFocus Wed, 03 Jun 2026 07:00:00 GMT
• crdf downgraded by craig-hallum -- price target lowered to $2.00 GuruFocus Wed, 03 Jun 2026 07:00:00 GMT
• onvansertib phase 2 results move cardiff oncology (nasdaq: crdf) toward phase 3 Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• craig-hallum downgrades cardiff oncology(crdf.us) to hold rating, announces target price $2 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• cardiff oncology (crdf) reports promising phase 2 results for on GuruFocus Tue, 02 Jun 2026 17:52:28 GMT
• Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-... GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• ASCO: Cardiff posts updated colorectal cancer data ahead of pivotal push Fierce Biotech Tue, 02 Jun 2026 07:00:00 GMT
• New colorectal cancer drug combo shows 72% response in trial Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• Cardiff Oncology reports positive phase 2 trial results for onvansertib Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• cardiff oncology announces positive phase 2 trial results for onvansertib in ras-mutated metastatic colorectal cancer, plans regis... Quiver Quantitative Tue, 02 Jun 2026 07:00:00 GMT
• asco: cardiff posts updated colorectal data before pivotal push Fierce Biotech Tue, 02 Jun 2026 07:00:00 GMT
• td cowen downgrades cardiff oncology(crdf.us) to hold rating, announces target price $1.9 富途牛牛 Tue, 02 Jun 2026 00:47:46 GMT
• crdf downgraded by hc wainwright & co. -- rating changed to neut GuruFocus Mon, 01 Jun 2026 15:07:46 GMT
• H.C. Wainwright cuts Cardiff Oncology stock rating on license termination Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• Clinical-stage biotech CEO in Jefferies health conference fireside chat Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Cardiff Oncology (CRDF) Files Lawsuit Against Nerviano Medical S GuruFocus Mon, 01 Jun 2026 07:00:00 GMT
• TD Cowen downgrades Cardiff Oncology stock rating on license dispute Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• Cardiff Oncology to present at Jefferies Global Healthcare Conference June 2-4, 2026 Pluang Mon, 01 Jun 2026 07:00:00 GMT
• TD Cowen Downgrades Cardiff Oncology(CRDF.US) to Hold Rating, Announces Target Price $1.9 Moomoo Mon, 01 Jun 2026 07:00:00 GMT
• cardiff oncology to participate in the jefferies global healthcare conference Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• cardiff oncology shares fall after hc wainwright, td cowen downgrades marketscreener.com Mon, 01 Jun 2026 07:00:00 GMT
• this craig-hallum analyst turns bearish; here are top 5 downgrades for monday Sahm Mon, 01 Jun 2026 07:00:00 GMT
• hc wainwright downgrades cardiff oncology to neutral from buy marketscreener.com Mon, 01 Jun 2026 07:00:00 GMT
• cardiff oncology, inc. 8-k filing details for may 27, 2026: company information, nasdaq listing, and key disclosures Minichart Sun, 31 May 2026 08:54:00 GMT
• cardiff oncology - nms informs cardiff oncology of agreement termination on may 27, 2026 TradingView Fri, 29 May 2026 07:00:00 GMT
• h.c. wainwright maintains cardiff oncology(crdf.us) with buy rating, maintains target price $10 富途牛牛 Thu, 28 May 2026 10:31:00 GMT
• cardiff oncology sets june asco data reveal as crdf stock test nears Bez Kabli Fri, 22 May 2026 07:00:00 GMT
• cardiff oncology announces webcast to discuss updated phase 2 crdf-004 data for onvansertib in first-line ras-mutated mcrc Sahm Fri, 22 May 2026 07:00:00 GMT
• cardiff oncology to host webcast on cancer trial data by investing.com Investing.com South Africa Fri, 22 May 2026 01:20:46 GMT
• new colorectal cancer trial data heads to asco, investor webcast june 3 Stock Titan Thu, 21 May 2026 21:03:06 GMT
• Cardiff Oncology Announces Webcast to Discuss Updated Phase GlobeNewswire Thu, 21 May 2026 07:00:00 GMT
• Cardiff Oncology to Host Investor Webcast on June 3 for CRDF-004 Data Update in RAS-Mutated Metastatic Colorectal Cancer Trial Quiver Quantitative Thu, 21 May 2026 07:00:00 GMT
• Cardiff Oncology to Present Updated Phase 2 CRDF-004 Onvansertib Data for First-Line RAS-Mutated mCRC Treatment in Webcast geneonline.com Thu, 21 May 2026 07:00:00 GMT
• Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• cardiff oncology sues nerviano as analyst backs onvansertib defense - cardiff oncology (nasdaq:crdf) Benzinga Wed, 20 May 2026 07:00:00 GMT
• william blair maintains cardiff oncology(crdf.us) with buy rating 富途牛牛 Wed, 20 May 2026 07:00:00 GMT
• cardiff oncology files lawsuit over onvansertib patent rights TipRanks Tue, 19 May 2026 22:38:07 GMT
• Cardiff Oncology, Inc. (CRDF) has filed documents with the U.S. Securities and Exchange Commission (SEC), disclosing that it has i... Bitget Tue, 19 May 2026 07:00:00 GMT
• [8-k] cardiff oncology, inc. reports material event | crdf 8-k filing Stock Titan Tue, 19 May 2026 07:00:00 GMT
• Cardiff Oncology Advances Onvansertib Phase 3 for RAS-Mutated Metastatic Colorectal Cancer The Clinical Trial Vanguard Mon, 18 May 2026 07:00:00 GMT
• cardiff oncology advances onvansertib to phase 3 in ras-mutated colorectal cancer The Clinical Trial Vanguard Sun, 17 May 2026 06:49:51 GMT
• Cardiff Oncology Advances Onvansertib Phase 3 for RAS-Mutated Colorectal Cancer The Clinical Trial Vanguard Sat, 16 May 2026 07:00:00 GMT
• is cardiff oncology (crdf) 5.1% undervalued after q1 2026 earnin GuruFocus Sat, 16 May 2026 04:45:28 GMT
• cardiff oncology earnings missed by $0.05, revenue fell short of estimates Investing.com Nigeria Fri, 15 May 2026 08:32:50 GMT
• a quick look at today's ratings for cardiff oncology(crdf.us), with a forecast between $6 to $10 富途牛牛 Fri, 15 May 2026 07:00:00 GMT
• cardiff oncology advances onvansertib to phase 3 for ras-mutated colorectal cancer The Clinical Trial Vanguard Fri, 15 May 2026 06:49:22 GMT
• william blair maintains cardiff oncology(crdf.us) with buy rating 富途牛牛 Fri, 15 May 2026 03:46:54 GMT
• cardiff oncology wins buy rating on strong phase 2 efficacy, fda-aligned phase 3 path, and broader onvansertib combination potenti... TipRanks Fri, 15 May 2026 03:00:54 GMT
• cardiff oncology (crdf) reports positive trial data and leadersh GuruFocus Fri, 15 May 2026 02:06:28 GMT
• cardiff oncology q1 net loss narrows as operating expenses fall TradingView Thu, 14 May 2026 22:19:33 GMT
• FDA meeting maps Phase 3 test of Cardiff's colorectal cancer drug Stock Titan Thu, 14 May 2026 07:00:00 GMT
• Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• Cardiff Oncology | 8-K: Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update Moomoo Thu, 14 May 2026 07:00:00 GMT
• cardiff oncology earnings missed by $0.05, revenue fell short of estimates Investing.com Thu, 14 May 2026 07:00:00 GMT
• cardiff oncology (crdf) reports positive trial data and leadersh GuruFocus Thu, 14 May 2026 07:00:00 GMT
• cardiff oncology (nasdaq: crdf) details q1 2026 loss and phase 3 plans Stock Titan Thu, 14 May 2026 07:00:00 GMT
• cardiff oncology (nasdaq: crdf) posts q1 loss, warns on cash and details onvansertib data Stock Titan Thu, 14 May 2026 07:00:00 GMT
• cardiff oncology, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 14 May 2026 07:00:00 GMT
• crdf stock price, quote & chart | cardiff oncology inc (nasdaq:crdf) ChartMill Wed, 13 May 2026 07:00:00 GMT
• crdf stock price, quote & chart | cardiff oncology inc (nasdaq:crdf) ChartMill Mon, 11 May 2026 07:00:00 GMT
• cardiff oncology inc expected to post a loss of 13 cents a share - earnings preview TradingView Mon, 04 May 2026 07:00:00 GMT
• h.c. wainwright maintains cardiff oncology(crdf.us) with buy rating, maintains target price $10 富途牛牛 Thu, 30 Apr 2026 09:52:20 GMT
• cardiff oncology reports inducement grant under nasdaq listing rule 5635(c)(4) The Manila Times Wed, 29 Apr 2026 07:00:00 GMT
Cardiff Oncology, Inc(NASDAQ:CRDF) 
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has c...
Website: https://cardiffoncology.com/
Founded: 1999
Full Time Employees: 12
CEO: Mark Erlander
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends